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Abstract
Background: The misuse and limited effectiveness of antibiotics for acute respiratory infections (ARIs) are well
documented, and current approaches targeting physicians or patients to improve appropriate use have had limited
effect. Shared decision-making could be a promising strategy to improve appropriate antibiotic use for ARIs, but
very little is known about its implementation processes and outcomes in clinical settings. In this matter, pilot
studies have played a key role in health science research over the past years in providing information for the
planning, justification, and/or refinement of larger studies. The objective of our study was to assess the feasibility
and acceptability of the study design, procedures, and intervention of the DECISION+ program, a continuing
medical education program in shared decision-making among family physicians and their patients on the optimal
use of antibiotics for treating ARIs in primary care.
Methods: A pilot clustered randomised trial was conducted. Family medicine groups (FMGs) were randomly
assigned, to either the DECISION+ program, which included three 3-hour workshops over a four- to six-month
period, or a control group that had a delayed exposure to the program.
Results: Among 21 FMGs contacted, 5 (24%) agreed to participate in the pilot study. A total of 39 family
physicians (18 in the two experimental and 21 in the three control FMGs) and their 544 patients consulting for an
ARI were recruited. The proportion of recruited family physicians who participated in all three workshops was 46%
(50% for the experimental group and 43% for the control group), and the overall mean level of satisfaction
regarding the workshops was 94%.
Conclusions: This trial, while aiming to demonstrate the feasibility and acceptability of conducting a larger study,
has identified important opportunities for improving the design of a definitive trial. This pilot trial is informative for
researchers and clinicians interested in designing and/or conducting studies with FMGs regarding training of
physicians in shared decision-making.
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The misuse and limited effectiveness of antibiotics for
acute respiratory infections (ARIs) are well documented,
and current approaches targeting physicians or patients
to improve appropriate use have had limited effect [1-4].
Only a few interventions combining physician, patient,
and public education have been successful in reducing
antibiotic prescribing for inappropriate indications [2].
In this regard, shared decision-making (SDM) could be
a promising strategy to improve appropriate antibiotic
use for ARIs [5].
SDM is a process by which a healthcare choice is made
by physician together with the patient and is charac-
terised by a two-way exchange of information, values,
and preferences, both parties taking steps to build a con-
sensus and reach an agreement on the decision to be
made [6,7]. From a patient’s perspective, SDM interven-
t i o n so rp r o g r a m s( i.e., patient decision aids) have been
found to improve knowledge of the options and accuracy
of the perception of their benefits and harms, to reduce
difficulty with decision-making, and to increase participa-
tion in the process [8]. Although expanding very rapidly,
SDM has not yet been adopted by physicians, and very
little is known about its implementation processes and
outcomes in clinical practices [9,10].
Decision-making occurring during a clinical encounter
between a patient and a physician is a complex and
highly interactive process. Although many studies have
attempted to capture the relational nature of this
encounter, members of this dyad have been mostly stu-
died independently, as if living in different worlds
[8,10,11]. Recent findings, however, have shown that
combining patients’ and their physicians’ perspectives
could enlighten the relational process occurring in the
encounter [12-14]. These findings suggest the need for a
better understanding of the impact of approaches such as
SDM, in which the involvement of both members of the
physician-patient dyad is emphasized. To our knowledge,
only a few studies have reported on the difficulties per-
taining to the implementation of this type of approach
[15-17]. One of the critical issues in this regard consists
of recruiting participants [15]. Indeed, recruiting and
retaining physicians as study participants have been
shown to be difficult, and even more so when it also
involves recruiting their patients [15-17]. Moreover,
simultaneous data collection at the point of care in physi-
cian-patient dyads generates further challenges, such as
having physicians complete questionnaires regarding
each recruited patient.
Pilot studies, in providing critical information on both
the processes and outcomes, offer a unique opportunity
to identify the difficulties of evaluating an intervention,
and thus enhance the rigour of larger full-scale studies.
There is growing interest in the use of pilot studies for
randomised trials [18-20], particularly if the planned
intervention is offered in pragmatic settings, that is, when
trials are designed to inform decisions about practice [21]
or when multifaceted interventions are at play [22-24].
Indeed, Campbell and colleagues (2000) [22] have recom-
mended a stepped approach to the development and eva-
luation of complex interventions, thus encouraging
exploratory and developmental research projects. Simi-
larly, the US Department of Veterans Affairs Quality
Enhancement Research Initiative has integrated pilot stu-
dies into their implementation process [23]. Many grant-
ing agencies now require pilot trials as safeguards to
ensure that future trials are designed optimally and can
be implemented in practice [25,26]. However, although
the importance and necessity of pilot studies have been
reported by many authors and institutions, there is a lack
of frameworks or recommendations on how to conduct,
assess, and interpret these studies [27-29].
In general, a pilot study is defined as a small-scale ver-
sion of anticipated research [18,19]. More specifically,
pilot work has been referred to as any background
exploratory research that may form the basis of a future
study [28,29], whereas the terms pilot studies or trials
have been recommended for studies with a specific
hypothesis, objective, and methodology, the latter includ-
ing a randomisation procedure [28]. Feeley and collea-
gues (2009) have recently proposed that the objectives of
pilot trials should relate to the feasibility and acceptability
of the intervention, study design and procedures, and the
determination of effect sizes [20]. According to these
authors, feasibility is primarily concerned with the
researcher’s ability to execute the plan (delivery), that is,
to provide the intervention and complete the study pro-
cedures, whereas acceptability concerns the suitability of
the intervention (uptake) or the research design from the
perspective of the participants [20]. Whether there are
many or few objectives in a pilot trial, the importance is
that specific objectives be established along with thresh-
old criteria for claiming success [18].
The current paper describes the recruitment process
and reports on the feasibility and acceptability of con-
ducting a larger clustered randomised trial of the DECI-
SION+ program, an innovative, theory-driven continuing
medical education (CME) program in SDM on the opti-
mal use of antibiotics for ARIs in primary care settings
among family physicians and their patients [30]. Specifi-
cally, the objectives of this pilot trial were to assess
(a) recruitment of family medicine groups (FMGs), family
physicians, and patients in the study; (b) participation of
family physicians to the DECISION+ program; and
(c) satisfaction of participants regarding the DECISION+
program. The development, adaptation, and validation of
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potential impact are reported elsewhere [30,31].
Methods
Study design
This study was a two-arm pilot clustered randomised trial.
FMGs, the unit of randomisation, were simultaneously
and randomly assigned using an Internet-based software
to either an experimental group in which participating
family physicians were provided the DECISION+ program
immediately or a control group in which exposure to the
DECISION+ program was delayed (Figure 1). The DECI-
SION+ program is a multifaceted intervention offered
over a four- to six-month period that includes three
3-hour interactive workshops, reminders of the expected
behaviours, and feedback.
Setting
The study was conducted in FMGs of Quebec City and
surrounding areas (Québec, Canada) between January
2007 and March 2008. FMGs are groups of family phy-
sicians (here referring to both family physicians and
general practitioners) who work in close cooperation
with nurses to offer family medicine services to regis-
tered individuals. During the last decade, in the province
of Québec, the Ministry of Health and Social Services
has provided incentives and support to private practi-
tioners to construct such primary care groups in order
to improve accessibility and continuity of care and facili-
tate interdisciplinary collaborations [32].
Study participants
FMGs were eligible if located in two pre identified health
regions (Capitale Nationale and Chaudière-Appalaches)
and if their family physicians were being paid fee-for-
services (in order to obtain data on medical service use
from the provincial claims data bank). Family physicians
from participating FMGs were excluded if they were cur-
rently involved or had previously participated in an
implementation study of SDM in clinical practice, or if
they did not plan to practice for the duration of the study
(e.g., pregnancy, retirement, practice restricted exclusively
to administrative duties). Patients, adults or children,
were included in the study if consulting a participating
family physician for an ARI and if an antibiotic treatment
was being considered by either the patient (or guardian)
or the family physician. Patients with a condition requir-
ing emergency care were excluded. Patients could take
part only once in the study. All participants, family physi-
cians and patients, signed an informed consent form
approved by the ethics committee from the university
hospital institutional review board.
Study procedures
Identification and selection of FMGs, family physicians, and
their patients
FMGs are accredited by the Ministry of Health and
Social Services of the Province of Québec. A list of all
accredited FMGs is available, free of charge, from the
Ministry’s website and is updated periodically [33].
FMGs from the two selected health regions were
retrieved and constituted the sample base for this
project.
Recruitment strategies for FMGs, family physicians, and
their patients
The medical director of each FMG was contacted in
random order by one of the two principal investigators
(FL and ML) after an initial introduction phone call by
a research assistant. When contacted, the director was
provided with information regarding the DECISION+
program, and a one-page summary of the project was
faxed. The director was requested to discuss potential
participation in the project with his/her colleagues. An
FMG could either accept or decline to participate at this
point. However, a short meeting between the research
team and FMG members was offered up-front to all
directors in order to facilitate decisions about participa-
tion in the study. All members of the FMG, including
nurses and practice managers, were invited to partici-
pate in this meeting. One of the principal investigators
Immediate DECISION+ group Delayed DECISION+ group
Baseline measures (FP)
PATIENT RECRUITMENT & DATA COLLECTION PERIOD I
See Figure 2
DECISION+ PROGRAM
Randomisation of FMGs
PATIENT RECRUITMENT & DATA COLLECTION PERIOD II
See Figure 2
PATIENT RECRUITMENT & DATA COLLECTION PERIOD III
See Figure 2
DECISION+ PROGRAM
Recruitment of FMGs
End of study measures (FP)
Identification and selection of FMGs
Figure 1 Study design. FMG = family practice group; FP = family
physician.
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attended the meeting to present the study to family phy-
sicians and to clarify concerns or ambiguities regarding
the program or the project. If at this point an FMG con-
firmed its participation, attending family physicians
immediately completed the consent form. Additional
information and consent forms were provided for family
physicians not attending the meeting, and they were
personally contacted by a research assistant one and two
weeks later if they had not returned the consent form.
Those who had still not responded after two weeks were
contacted personally by one of the two principal investi-
gators. If a given FMG decided to delay its acceptance
or refusal to participate in the study, the research assis-
tant or one of the principal investigators would contact
the medical director once a week until receiving a final
answer. Participating family physicians were offered
CME credits upon the completion of the program and
the opportunity to keep all the materials and tools
offered during the project. No financial incentive was
offered during the study beyond the usual Provincial
Government subsidy provided to all family physicians
participating in a three-hour-a-day-accredited CME
activity.
Fifteen patients per family physician were recruited,
five per data collection period (Figure 1). Family physi-
cians were not directly involved in the recruitment of
patients. They were recruited during walk-in clinic
hours at each participating FMG by research assistants
that were stationed in the FMG waiting room. Posters
were displayed in the waiting room and flyers were
available at the registration office to facilitate the
recruitment process. Patients interested in the trial met
with the research assistant in order to verify eligibility
for the study. Patients had to be seeking a consultation
for an ARI (acute otitis media, acute bronchitis, acute
sore throat, or acute rhinosinusitis) and considering the
use of antibiotics in order to be eligible for the study.
No incentives or privileges were offered to participating
patients.
Retention strategies and burden to participants
The disruption of office routine was kept to a minimum.
Research assistants were responsible for all stages of the
recruitment process and served as the primary means of
communication between the research team and the
FMG manager and participating family physicians. They
maintained regular contact (i.e., phone calls, emails, per-
sonal visits) with the practice manager, the medical
director of the FMG, and reception staff to sustain and
reinforce commitment to the project. The research team
provided a biweekly bulletin to keep FMGs and their
family physicians informed about the progression of the
study and about any recent findings regarding antibiotic
use for ARIs, when available. The research team ensured
that the questionnaires, when possible, were completed
during a planned activity (e.g., workshops/staff meeting).
Intervention (the DECISION+ program)
The intervention was based on a conceptual framework
integrating the principles of SDM, including evidence-
based medicine and patients’ involvement in decisions
[30]. According to this framework, greater understand-
ing of the probabilistic nature of bacterial infection in
ARIs, better knowledge and communication of the bene-
fits and risks, and active participation of the patient in
the decision-making process should lead to SDM. In
turn, this should favor optimal prescription of antibio-
tics by physicians and uses of antibiotics by patients
and, therefore contributing to better health outcomes.
The development of the program was under the super-
vision of the principal investigators, two family physicians
(an epidemiologist expert in evidence-based medicine
and an expert in SDM and its implementation in primary
care), in collaboration with two CME university offices.
All three workshops and material were pretested with a
panel of family physicians and experts from various
related fields (e.g., anthropology, medical education,
epidemiology, education, and medicine).
Workshops
A series of three 3-hour workshops were offered over a
period of four to six months to participating family phy-
sicians. The workshops were based on learning princi-
ples in medical education and addressed specific key
components of the study framework [30]. They were
adapted from previous work by one of the principal
investigator [13]. The first workshop focused on the
probabilistic nature of the diagnosis of a bacterial versus
viral ARI. The second workshop focused on the avail-
able evidence regarding risks and benefits when facing a
decision about whether to use antibiotics in ARI. It also
addressed effective strategies to communicate this infor-
mation to patients. The third workshop focused on stra-
tegies to foster active participation of patients in the
decision-making process. Each workshop included
videos and reflective exercises that facilitated group dis-
cussion. Various decision-ma k i n gs u p p o r tt o o l sa sw e l l
as a toolkit that contained the materials of the workshop
were also made available to the participants. The work-
shops were led by the two principal investigators,
accompanied by a research assistant.
The decision support tools
The decision support tools included four sections: (1) a
diagnostic aid for physicians to better appraise the prob-
abilistic nature of the diagnosis of a bacterial versus
viral ARI, (2) a graphic display of the benefits and risks
of antibiotic use for ARIs to be shared with their
patients, (3) a section helping patients to elucidate their
values and preferences regarding the benefits and risks
of using or not using antibiotics, and (4) a section
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first two sections were based on the best scientific evi-
dence regarding the probabilistic nature of the diagnosis
of an ARI and the effectiveness of antibiotics for treating
ARIs. The remaining sections were adapted from the
O’Connor generic decision aid [34] and included the
SURE tool, which assesses the comfort with the decision
that was made [35]. Family physicians were given the
first section of the decision support tools at the first
workshop and were strongly encouraged to try it out
with their patients before the next workshop. The other
sections were subsequently added during the subsequent
workshops with the same recommendations. A global
decision support tool that integrated all sections was
provided at the end of the program.
Reminders of expected behaviours and feedbacks
Aside from the biweekly progression bulletin, one-sheet
letter-size paper reminders reemphasizing the use of the
decision support tools discussed in a previous workshop
were sent to participating family physicians every one to
two weeks after the first and second workshops. During
the third workshop, family physicians were provided
with individual feedback on the agreement with their
patients’ evaluations on comfort with the decision to use
or not to use antibiotics in ARI. In addition, they were
informed of the pooled results from their colleagues.
Time was made available during the workshop to
explain how to interpret the results. This information
was collected at the time of the first data collection per-
iod (the first five patients per physician) prior to expo-
sure to the workshop (Figure 2).
Participation and satisfaction of family physicians
regarding the intervention
To facilitate attendance, workshops were offered at the
site of each participating FMG. Family physicians not
a v a i l a b l ea tt h a tt i m ew e r eg i v e nt h eo p p o r t u n i t yt o
attend the workshop of another FMG within their study
group (immediate or delayed). All family physicians
received copies of the program material. Family physi-
cians were considered to be collaborators and were
invited to give their insights. This resulted in open dis-
cussions regarding logistical aspects of the project fol-
lowing each workshop. Family physicians also completed
a questionnaire regarding their level of satisfaction with
the CME program, and they had the opportunity to
express anonymous comments on the project.
Data collection
Data about the organisation were collected from partici-
pating FMGs at the beginning of the study. Modifications
to the FMG status or staff or significant events occurring
in the participating FMG throughout the study period
were also recorded. Sociodemographic variables along
with entry/exit measures were collected from family physi-
cians through self-reporting questionnaires before the first
and after the last patient recruitment period (Figure 1).
Postclinical encounter data were collected from family
physicians for each of their recruited patients during each
recruitment period (Figure 2). Questionnaires were
attached to patient’s medical records, which encouraged
family physicians to complete them at the same time.
Patient data were collected using self-reporting question-
naires completed before and after the consultation and
one week after the consultation by telephone interview
(Figure 2).
Outcome measures
Feasibility (delivery) and acceptability (uptake) of the
DECISION+ program were the main outcome measures
of this pilot trial. Investigators had established ap r i o r i
threshold for specific feasibility and acceptability criteria.
These were the following: (a) the proportion of contacted
FMGs participating in the pilot study would be 50% or
greater, (b) the proportion of recruited family physicians
participating in all three workshops would be 70% or
greater, (c) the mean level of satisfaction from family
physicians regarding the workshops would be 65% or
greater, and (d) the proportion of missing data in each
completed questionnaire would be less than 10%.
Satisfaction with the program was measured using a
standardised CME satisfaction questionnaire from the
CME university office. This questionnaire contains 13
items, each assessed on a four-point (1 = completely dis-
agree to 4 = completely agree) Likert-scale, related to
the relevance and scientific quality of the content, the
educational structure of the workshops, the trainers, and
the workshops in general.
After the onset of the trial, investigators and the
research team met regularly (biweekly or monthly steer-
ing group meetings) to evaluate the progress of the
study and to overcome or discuss issues and barriers
that had arisen. These evaluations were based on reports
from on-site research assistants and comments and
Baseline measures 
One-week telephone
follow-up
CLINICAL ENCOUNTER
Patient recruitment
Five patients per FP Participating FP
FMG OUTPATIENTS/WALK-IN CLINICS
To study’s next step
Postencounter 
measures (PT)
Postencounter 
measures (FP)
Figure 2 Patient recruitment and data collection periods I, II, &
III. FMG = family practice group; FP = family physician; PT =
patients.
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shops. Thus, retention and burden outcomes were
added to the preestablished outcomes. The appropriate-
ness of selection, timing, and sequencing of similar
study measures for patients and their family physicians
were also documented.
Secondary outcome measures are detailed and
reported elsewhere [30,31]. Briefly, both family physi-
cians and patients completed similar questionnaires per-
taining to the decision to use or not to use antibiotics,
their comfort with the decision (Decisional Conflict
Scale) [36], and their intention to engage in SDM in
future encounters for ARIs [30]. Family physicians
further reported their intention to use clinical practice
guidelines pertaining to the use of antibiotics in ARI.
Patients reported on their regrets regarding the decision
that was made (Decisional Regret Scale) [37]. The pre-
scription profile of antibioti c si nA R I so fp a r t i c i p a t i n g
family physicians was also collected from the provincial
registry for patients covered by the public drug plan.
Results
Identification, selection, and recruitment of participants
(feasibility)
According to the list extracted from the Ministry of
Health and Welfare web-based registry, there were 24
accredited FMGs in the two selected health regions at
the time of recruitment. In total, 21 FMGs were eligible
(Figure 3).
A research assistant made 41 introductory phone calls
to contact the medical directors of the 21 eligible FMGs
over a four-week period. One director could not be con-
tacted. Information leaflets were faxed to the 20 con-
tacted FMGs. Second attempts by the research assistant
to assess willingness to participate in the study or to
attend an information meeting resulted in 39 calls over
an 11-week period. Twelve FMGs declined participation
in the study and eight FMGs agreed to meet with the
research team. After the meeting, a total of 36 additional
calls over a period of nine weeks were necessary to get a
final answer. Four FMGs agreed to participate. Two
were randomly assigned to the experimental group
(immediate DECISION+ program) and two to the con-
trol group (delayed DECISION+ program). A fifth FMG
accepted too late to be randomised and was assigned to
the control group, for a total of five (24%) contacted
FMGs participating in the study (Figure 3).
Out of the 52 eligible family physicians working in
the five participating FMGs, 39 (75%) agreed to partici-
pate in the study. Proportions of participating family
physicians in the two experimental and three control
FMGs were 90% and 66%, respectively. The character-
istics of family physicians by study groups are detailed
in Table 1.
A total of 544 patients were recruited, and 510 (94%)
were contacted one week after the medical visit. On
average, there were 5.3 patients recruited per family
physician per period per group. Patients’ characteristics
are reported in Table 2. The first patient recruitment
period lasted 9 weeks and took place during the winter
of 2007, while the second and third periods lasted,
r e s p e c t i v e l y ,1 7a n d9w e e k sa n dt o o kp l a c ed u r i n gt h e
summer of 2007 and winter of 2008.
Retention of participants in the study and data collection
(feasibility and acceptability)
All five FMGs completed the study. A total of 36 (92%)
family physicians completed the study (Figure 3). All
family physicians and patients completed the baseline
questionnaire and the questionnaires after each clinical
encounter. Thirty (83%) of the 36 family physicians that
completed the study completed their end-of-study ques-
tionnaire. The proportion of missing items in the com-
pleted questionnaires was less than 8% for each data
collection period.
Intervention (feasibility)
A total of 15 workshops were offered, for a total of
45 hours. Five of the six workshops in the experimental
group (immediate) were offered by both principal inves-
tigators, whereas the remainder was offered by one of
the principal investigator and a collaborator in the
study. None of the workshops was reassigned. In the
control group (delayed), only one of the nine workshops
was offered by both principal investigators. Six work-
shops were offered by one principal investigator and a
collaborator, one was offered by one principal investiga-
tor only, and one was conducted by two collaborators.
Two workshops had to be reassigned because of antici-
pated poor attendance or the unavailability of principal
investigators or collaborators.
Participation and satisfaction of family physicians
(acceptability)
Overall, 29 (74%) family physicians participated in the
first workshop, 27 (69%) in the second workshop, and
22 (56%) in the third workshop (Table 3). Although
27 (69%) family physicians attended two or more work-
shops, the proportion of recruited family physicians who
participated in all three workshops was 46%. Details of
participation according to study groups are presented in
Table 3.
Global mean levels of satisfaction for the workshops in
the immediate and delayed groups were, respectively,
97% and 98% for the first workshop, 96% and 90% for
the second workshop, and 95% and 89% for the third
workshop. The overall level of satisfaction of family phy-
sicians for the workshops of the DECISION+ program
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Page 6 of 12Eligible FMG to be contacted by PI: n = 21
FMG RANDOMISED: n = 4
On-site meeting: n = 8
IMMEDIATE D+ Group (FMG): n = 2
RECRUITED FP: n = 18
Declined: n = 2
Eligible FP: n = 20
DELAYED D+ Group (FMG): n = 2 (+1)
Withdrawn: n = 2
• Deceased (n = 1)
• Too busy (n = 1)
Gave a late positive responsea: n = 1
RECRUITED FP: n = 21
Declined: n = 11
Eligible FP: n = 32
Withdrawn: n = 1
• Promoted (n = 1)
Identified FMG: n = 24
Not meeting inclusion criteria: n = 3
• In a teaching hospital (n = 2)
• In a community health centre (n = 1)
• Unable to reach Director: n = 1
• Declined on-site meeting: n = 12
• Length of workshop (n = 5)
• Lack of time for research (n = 3)
• Not interested in clinical topic (n = 3)
• Involved in other projects (n = 1)
n
Declined the invitation: n = 3
• Length of workshop (n = 2)
• In a reorganisation process (n = 1)
Figure 3 Recruitment and retention of FMGs and family physicians.
aThis FMG was not randomised in order to avoid breaking the
allocation of concealment. FMG = family medicine group; D+ = DECISION+ pilot trial; FP = family physician; PT = patients; PI = principal
investigator.
Table 1 Characteristics of participating family physicians (n = 39)
Characteristics Immediate DECISION+ (n = 18) Delayed DECISION+ (n = 21) Total
Age, yrs (mean ± SD) 48 ± 9 49 ± 7 48 ± 8
Years in practice (mean ± SD) 22 ± 9 23 ± 9 22 ± 9
Hours/week of professional activities (n = 36) (mean ± SD) 45 ± 11 46 ± 13 46 ± 12
Number of patients per week (mean ± SD) 105 ± 47 113 ± 29 109 ± 38
Women (%) 10 (56) 10 (48) 20 (51)
Preference of decision-making style [45]
Patient alone 4 (22) 0 (0) 4 (10)
Patient after considering physician’s opinion 4 (22) 9 (43) 13 (33)
Patient and physician 3 (17) 4 (19) 7(18)
Physician after considering patient’s opinion 6 (33) 8 (38) 14(36)
Physician alone 1 (6) 0 (0) 1(3)
SD = standard deviation.
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evaluated were similar to global mean levels and, thus,
are not reported in detail.
Discussion
To the best of our knowledge, this paper is among the
first to describe in detail the recruitment process of
FMGs, family physicians, and patients to a pilot trial of
the DECISION+ program, a CME program in shared
decision-making on the optimal use of antibiotics for
treating ARIs in primary care practice. Moreover, the
results of this trial support the feasibility and acceptabil-
ity of conducting a large clustered randomised trial
involving dyads of family physicians and their patients
in SDM regarding the optimal use of antibiotics for
ARI. This conclusion is reached even if not all predeter-
mined standards for our criteria were always fully met.
Indeed, it has been established that not reaching the
preestablished criteria does not necessarily indicate
unfeasibility of the trial but rather underlines changes to
be made to the protocol [28].
Identification of FMGs and associated family physi-
cians was a relatively simple process. The necessity for
FMGs to be accredited, the relative stability of these
FMGs, and the availability of a free web-based registry
facilitated this process. Identification of individual family
physicians would have been more difficult because avail-
able registries are rapidly outdated [15].
The main difficulty in recruitment appeared during
the initial contact by the principal investigator with the
medical director of the FMG. Twelve FMGs (57%)
declined the invitation even before the face-to-face
meeting. Thus, 24% of the eligible FMGs agreed to take
part in the study, less than the 50% expected. We were
probably too confident when targeting a 50% positive
response rate from all identified FMGs. Recent studies
regarding appropriate use of antibiotics reported recruit-
ment rates for groups of providers of 56% and 37%
[38,39]. Recruitment rates were poorly reported, when
reported at all, in other similar studies [10,40], despite
Table 2 Patients’ characteristics
Patient recruitment
phases
Characteristics Phase I Phase
II
Phase
III
Total number of patients 199 181 164
Adults/Children ratio (<14 years old) 136/63 118/63 124/40
Age, years (mean ± SD)
Children (<14 years old) 5 ± 4 6 ± 4 4 ± 4
Adults 42 ± 14 39 ± 15 40 ± 13
Male, frequency (%)
Children (<14 years old) 33 (52) 36 (57) 21 (53)
Adults 42 (31) 42 (36) 36 (29)
Health condition
Very good 71
(35.7)
94
(52.0)
73
(44.5)
Average 96
(48.2)
69
(38.0)
71
(43.3)
Problematic 31
(15.6)
18
(10.0)
20
(12.2)
Did not respond 1 (0.5)
Education level
High school or less 87
(43.7)
70
(38.7)
58
(35.4)
College 62
(31.2)
54
(29.8)
55
(33.5)
University 49
(24.6)
54
(29.8)
49
(29.9)
No response 1 (0.5) 3 (1.7) 2 (1.2)
Employment status
Working 147
(73.9)
139
(76.8)
137
(83.5)
Not working 17 (8.5) 7 (3.9) 2 (1.2)
Other 17 (8.5) 9 (4.9) 10 (6.1)
No response 18 (9.1) 26
(14.4)
15 (9.2)
Family income
<$15,000 16 (8.0) 23
(12.7)
6 (3.7)
$15,000-$29,999 34
(17.1)
17 (9.4) 18
(11.0)
$30,000-$44,999 37
(18.6)
31
(17.1)
25
(15.2)
$45,000-$59,999 25
(12.6)
31
(17.1)
27
(16.5)
≥$60,000 79
(39.7)
70
(38.7)
76
(46.3)
No response 8 (4.0) 9 (5.0) 12 (7.3)
Type of health insurance, private
a 149
(74.9)
118
(65.2)
131
(79.9)
Did not respond 1 (0.6)
Preferred role in decision making
Table 2 Patients?’? characteristics (Continued)
Patient alone 9 (4.5) 10 (5.5) 7 (4.3)
Patient after considering physician’s
opinion
62
(31.2)
71
(39.2)
54
(32.9)
Patient and physician 55
(27.6)
39
(21.6)
37
(22.6)
Physician after considering patient’s
opinion
47
(23.6)
39
(21.6)
38
(23.2)
Physician alone 22
(11.1)
22
(12.1)
26
(15.8)
Did not respond 4 (2.0) 2 (1.2)
aAll others are public health insurance.
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regarding generalisability of results. The main reason for
refusal from the FMG was that participation would add
unnecessary workload (nine hours of workshops) to
already too busy family physicians or that the clinical
topic was felt to be irrelevant for their CME activities at
that time. In addition, the project was carried out at the
time that some FMGs were in the implementation
phase, and this reorganisation process might have con-
tributed to the smaller than anticipated number of
acceptance.
Nonetheless, it is interesting to note that out of the
e i g h tF M G st h a ta g r e e dt oa no n - s i t em e e t i n g ,f o u r
immediately accepted the invitation to participate in the
study. This suggests that having the opportunity to clar-
ify face-to-face the nature of the study and the time and
efforts required from participants may facilitate the
recruitment process when participants are interested in
learning about the study. According to Dormandy and
colleagues (2008), factors that appeared important in
retaining practices in a study are good communication,
easy collection methods, and payment of incentives as
scheduled [41]. At the time of the first contact, the issue
of incentive was not discussed with the FMG. This did
not seem to affect their agreement to participate or not
after the meeting, as none of the FMGs reported the
lack of payment as a reason for refusal. This reinforced
earlier findings showing that financial incentive alone is
not sufficient for a high recruitment rate [15,17]. More-
over, the acceptance rate from family physicians from
these FMGs was high. Indeed, 75% of family physicians
agreed to take part in the study. It should, however, be
noticed that acceptance by the FMG was probably
dependant on acceptance by a large proportion of its
family physicians.
Conducting studies with family physicians and their
patients is challenging, mostly as a result of the compet-
ing time demands of family physicians for other clinical
and administrative tasks [15,17]. Furthermore, it is one
thing to take part in a study and facilitate recruitment
of patients for the research team, but to have to com-
plete documentation for each patient after each of their
encounters is a major challenge. To cope with these
issues, the strategies used by this research were to mini-
mise the burden on the family physicians by having
research members take care of all study-related tasks, as
done in previous work [13]. This appears to have been
very successful since the retention rate of all participants
was very high. The number of patients per physician
was also kept to a minimum.
As for patients, the challenge was to proceed to
recruitment in the FMG waiting room, without disrupt-
ing or delaying the patients’ consultation flow. Having
research assistants recruiting patients minimised a
potential selection bias if recruitment had been driven
by family physicians and maximised the recruitment
rate, as recruitment driven by physicians is usually only
moderately successful [17].
Considering their busy schedules, we anticipated that
collecting information from physicians after each clinical
encounter would be challenging, and therefore, we were
particularly interested in the proportion of missing post-
encounter questionnaires. Surprisingly, all completed the
questionnaires (100% completion rate), and there were
very few missing data, suggesting that it is possible to
collect similar and simultaneous measures from both
family physicians and their patients. Factors that might
have contributed to this high rate could include the fact
that postencounter questionnaires were very short
(approximately two to three minutes to complete) and
were included with the patient’s medical file so that they
could be completed at the same time as the medical
note. Furthermore, completion is likely to have been
enhanced by the presence of a research assistant who
reminded physicians of their task.
Based on this pilot trial, the planning of the recruit-
ment of participants for a larger trial needs to be care-
fully thought out. Although demanding for principal
investigators, having a meeting with members of the
FMGs seems to be useful, as it could have reinforced
the decision to participate in this type of study. More-
over, it could have led to a more informed consent, con-
ducive to sustained participation. Second, recruiting
patients particularly in the context of ARI also needs to
be carefully planned. One of the data collection periods
occurred during summertime, when patients consulting
for ARIs are less frequent, and thus, the time for collec-
tion period was longer than anticipated. Third, the pilot
study was limited to FMGs, as they had a fee-for-service
organisation, but other primary care groups might be
Table 3 Attendance and numbers of workshops completed by family physicians
Attendance at the workshops n (%) Number of workshops completed n (%)
Workshop 1 Workshop 2 Workshop 3 0 1 2 3
Immediate D+ group (n = 18) 15 (83) 13 (72) 11 (61) 1 (6) 4 (22) 4 (22) 9 (50)
Delayed D+ group (n = 21) 14 (67) 14 (67) 11 (52) 5 (24) 2 (9) 5 (24) 9 (43)
Total 29 (74) 27 (69) 22 (56) 6 (16) 6 (16) 9 (23) 18 (46)
D+ = DECISION+ continuing medical education program.
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units could be an interesting group to target, as they are
usually larger in size than FMGs and have more physi-
cians, including residents. Regardless of study type or
method, successful identification, selection, and recruit-
ment of participants, whether they are groups of physi-
cians, individual physicians, or patients, are important
issues to be considered by all intending researchers [15],
and pilot trials provide such opportunities.
Regarding participation in the DECISION+ program, a
total of 46% of all participating family physicians com-
pleted the three 3-hour workshops, for a total of nine
h o u r so v e rf o u rt os i xm o n t h s .W eh a dm a d eap r i o r i
acceptability criteria that a 70% participation rate would
be ideal for the success of a larger-scale study. Considera-
tions need to be taken and lessons learned. Findings from
a recent systematic review on the adoption of SDM by
providers revealed that participation of providers in the
intervention varied between 47% and 100%, with a med-
ian of 52%, independent of the length of the intervention
[10]. Moreover, a recent study reported that a six-hour
workshop for practitioners seems the ideal length of
time, independent of numbers of workshops [42]. In ret-
rospect, inserting three workshops of three hours over a
four- to six-month period was probably too demanding
on the part of family physicians in FMGs who usually
have other hospital, educational, and administrative
duties. In light of these results, having 69% of the family
physicians participating in two or more workshops (six
hours or more) in this pilot trial seems acceptable. The
burden associated with the numbers and lengths of the
workshops were also demanding on the trainers who
could not comply with all competing demands, which
affected the replicability of the intervention in the control
group, as reported elsewhere [31].
Considering all these elements, the length and dura-
tion of the workshop should be considered when plan-
ning and conducting a larger trial to increase
generalisability of the intervention. Introduction of a
web-based or self-learning element, reduction of the
length and/or numbers of workshops for both participants
and trainers, and improvement of train-the-trainers strate-
gies for collaborators needs to be considered.
Limitations need to be acknowledged. First, the pilot
study was limited to FMGs, as they had a fee-for-service
organisation, but other primary care groups might be
considered for a larger trial. Second, the low response
rate of FMGs may limit the generalisability of the find-
ings, although the sociodemographic characteristics of
participating family physicians were similar to the char-
acteristics provided by the provincial registry (data not
shown). Third, we lacked information regarding the
number of patients that presented themselves at the
outpatient clinics for an ARI and the total number of
patients seen by physicians during the study period.
Finally, it is possible that FMGs, family physicians, and
patients who participated in the study might have had
higher interest or motivation in the DECISION+ pro-
gram than those who did not participate in the study.
Notwithstanding these limitations, rigorous pilot trials
are meritorious projects, and their results should be
subjected to the same level of scrutiny and require-
ments as those provided to the results of full-scale trials
[28]. However, opinions vary regarding whether the
results of the pilot trial should focus on the implemen-
tation processes, efficacy outcomes, or both [20]. Publi-
cation of findings of pilot trials could certainly help to
inform other researchers about methodological or prac-
tical challenges related to such studies and does consti-
tute a meaningful contribution to the literature
[27,43,44].
Conclusions
The present study has highlighted the significant practi-
cal and methodological issues in undertaking a clustered
randomised trial involving family physicians and their
patients while minimising burden on the normal state of
the clinical encounters. This pilot trial will help to better
define a larger cluster trial concerning the evaluation of
an intervention targeting the improvement of the SDM
process among family physicians and their patients
regarding the use of antibiotics for treating ARIs in pri-
mary care.
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